Drugs / 123I-ADAM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01160263 | Oct 2012 → Oct 2014 | amyotrophic lateral sclerosis | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123I-ADAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160263 ↗ |